Seachadadh Intíre SAM, Ceanada Seachadadh Intíre, Seachadadh Intíre na hEorpa

Muroasone furoate (83919-23-7)

Rátáil: SKU: 83919-23 7-. Catagóir:

Tá AASraw le sintéis agus le cumas táirgthe ó ghram go hord maise Mometasone furoate (83919-23-7), faoi rialachán CGMP agus córas rialaithe cáilíochta inrianaithe.

Cur síos ar an Táirge

Mometasone furoate (83919-23-7) video


Mometasone furoate (83919-23-7) Sairgeadú:

Struchtúr Ceimiceach: Ainm Táirge: Mometasone furoate
Cas Uimh: 83919-23 7-
Foirmle mhóilíneach: C27H30Cl2O6
Meáchan Mhóilíneach: 521.4
Comhchiallaigh:mometasone furoate

83919-23 7-

Nasonex

Asmanex

Elocon

Stóráil: Tirim, dorcha
Doiciméid (COA & HPLC etc.): Ar fáil

Mometasone furoate (83919-23-7) Description:

Mometasone Furoate is the furoate salt form of mometasone, a synthetic topical glucocorticosteroid receptor agonist with anti-inflammatory, anti-pruritic and vasoconstrictive properties.

Mometasone furoate exerts its effect by binding to cytoplasmic glucocorticoid receptors and subsequently activates glucocorticoid receptor mediated gene expression. This results in synthesis of certain anti-inflammatory proteins, while inhibiting the synthesis of certain inflammatory mediators.

Specifically, mometasone furoate appears to induce phospholipase A2 inhibitory proteins, thereby controlling the release of the inflammatory precursor arachidonic acid from phospholipid membrane by phospholipase A2.

Tagairt:

  • 1: Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev. 2013 Dec 2;12:CD005149. doi: 10.1002/14651858.CD005149.pub4. Review. PubMed PMID: 24293353.
  • 2: Ellis AK, North ML, Walker T, Steacy LM. Environmental exposure unit: a sensitive, specific, and reproducible methodology for allergen challenge. Ann Allergy Asthma Immunol. 2013 Nov;111(5):323-8. doi: 10.1016/j.anai.2013.07.019. Review. PubMed PMID: 24125135.
  • 3: Lee JT, Han JK. Sinus implants for chronic rhinosinusitis: technology evaluation. Expert Opin Drug Deliv. 2013 Dec;10(12):1735-48. doi: 10.1517/17425247.2013.839654. Epub 2013 Oct 3. Review. PubMed PMID: 24088141.
  • 4: Nannini LJ, Poole P, Milan SJ, Kesterton A. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2013 Aug 30;8:CD006826. doi: 10.1002/14651858.CD006826.pub2. Review. PubMed PMID: 23990350.

RÉITIGH AGUS SÉANADH:

Tá an t-ábhar seo díolta le haghaidh taighde amháin. Téarmaí Díolacháin Cuir iarratas isteach. Ní le haghaidh Tomhaltas Daonna, ná le haghaidh Úsáidí Liachta, Tréidliachta nó Teaghlaigh.


COA

HNMR

Tagairtí agus luachanna táirge